Kiniksa Pharmaceuticals
KNSA
#3922
Rank
โ‚ฌ2.80 B
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
36,69ย โ‚ฌ
Share price
-0.14%
Change (1 day)
107.60%
Change (1 year)

EPS for Kiniksa Pharmaceuticals (KNSA)

EPS in 2025 (TTM): 0,69ย โ‚ฌ

According to Kiniksa Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is 0,68ย โ‚ฌ. an increase over its 2024 EPS that were of -0,52ย โ‚ฌ.

EPS history for Kiniksa Pharmaceuticals from 2018 to 2025

Annual EPS

Year EPS Change
20250,64ย โ‚ฌ-222.95%
2024-0,52ย โ‚ฌ-421.05%
20230,16ย โ‚ฌ-92.8%
20222,25ย โ‚ฌ-214.78%
2021-1,96ย โ‚ฌ-10.85%
2020-2,20ย โ‚ฌ-14.57%
2019-2,58ย โ‚ฌ6.33%
2018-2,42ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,48ย โ‚ฌ-316.25%๐Ÿ‡บ๐Ÿ‡ธ USA